Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Natalie Wallace (NPI 1386059061)

Field	Value
Entity Type	Individual
Organization	Natalie Wallace
Address	3851 Piper Street Suite U340
City	Anchorage
State	AK
ZIP	99508
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	June 21, 2014

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider is effectively single‑payer at the claim level: Total Medicare revenue: $1.2M while Total Medicaid revenue: none (no Medicaid billing on file). The absence of any Medicaid billing on file indicates Medicare dominates the displayed clinical and financial activity for this NPI.

Revenue is highly concentrated in a small set of injectable oncology agents: the precomputed top 3 Medicare codes by revenue account for 81.6% of this provider's total Medicare revenue, led by J9271 with $817K revenue (66.8% of Medicare revenue), followed by J0897 with $104.9K (8.6%) and J9312 with $75.5K (6.2%). This degree of concentration means a single drug (J9271) represents the majority of reported Medicare dollars.

The code mix and dollar distribution point to an outpatient infusion‑focused hematology/oncology practice: dominant drug codes (J9271, J0897, J9312) are high‑cost monoclonal antibody/immunotherapy injections, supported by chemotherapy administration codes such as 96413 (314 claims, $37.1K revenue, 3.0%) and add‑on infusion codes like 96417 ($8.2K, 0.7%). Supportive biologic use is also visible via Q5111 (408 claims, $44.1K revenue, 3.6%), consistent with routine management of oncology patients receiving systemic therapy.

Clinical complexity in office practice is above typical for national peers: 99215 appears with 266 claims, $48.1K revenue (3.9%) and ranks #7304 of 145531 providers nationally (95th percentile; notably above typical national volume for this code), indicating a relatively high volume of complex evaluation and management visits alongside infusion services. Lower‑level E/M codes (99214, 99213) are present but account for smaller shares of revenue, reinforcing a focus on higher‑complexity encounters.

Competitive standing is mixed across specific drugs: J9271 (rank #447 of 1841, 75th percentile) and J0897 (rank #2550 of 10057, 74th percentile) are characterized as typical, unremarkable national volumes, whereas J9312 is reported as rank #311 of 317 (2th percentile) yet is still labeled in the file as typical, unremarkable volume for that code. Meanwhile, the high percentile standing for 99215 (95th percentile; notably above typical national volume) marks the provider as an above‑typical performer for complex office visits even if drug volumes are generally typical.

From a payer or contracting perspective, the practice’s financial profile indicates concentration risk: a majority of Medicare dollars flow through a single agent (J9271 at $817K, 66.8%), so shifts in prescribing patterns, reimbursement, or access to that agent would materially affect reported Medicare revenue. Payers should note that utilization is tightly linked to high‑cost infusible therapies rather than broad outpatient visit volume alone.

The provider has an established NPI history and specialty alignment consistent with these activities: NPI enumerated (registered): 2014-06-21 (~12 years ago), Taxonomy: Hematology & Oncology Physician, City: ANCHORAGE, State: AK. That tenure and specialty designation support the interpretation of a sustained outpatient oncology infusion practice operating in the Anchorage market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

36 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	19,000	$40	$817K
J0897	Injection, denosumab, 1 mg	5,520	$20	$104.9K
J9312	Injection, rituximab, 10 mg	1,180	$60	$75.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	270	$180	$48.1K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	410	$110	$44.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	310	$120	$37.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	230	$130	$28.9K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	50	$220	$10.5K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	140	$60	$8.2K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	40	$200	$7.7K

Showing 1–10 of 36

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 36 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Natalie Wallace — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

36 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	4	10	13,300	$40	$609.5K
J9312	4	10	2,330	$60	$168.4K
J0897	10	30	2,700	$20	$82.7K
Q5111	3	10	700	$110	$71.7K
96413	7	20	230	$110	$30.2K
99233	170	190	80	$120	$17.1K
99214	269	1,210	90	$100	$16.2K
74177	52	60	80	$110	$15.5K
99232	263	280	80	$80	$14K
99215	19	400	40	$150	$11K

Showing 1–10 of 36

Related Providers

Other providers that share a Tax Identification Number (TIN) with Natalie Wallace, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Steven Liu	AK	Hematology & Oncology Physician	$3.4M	$0
Max Rabinowitz	AK	Hematology & Oncology Physician	$2M	$0
Shannon Smiley	AK	Hematology & Oncology Physician	$1.6M	$0
Theodore Kim	AK	Hematology & Oncology Physician	$1.2M	$0
Katmai Oncology Group, LLC	AK	Medical Oncology Physician	$0	$872.8K
Ellen Chirichella	AK	Hematology & Oncology Physician	$855.8K	$0
Alaska Oncology And Hematology LLC	AK	Hematology & Oncology Physician	$0	$375.5K
Kendal Webb	AK	Hematology & Oncology Physician	$292.4K	$0
Mary Klix	AK	Hematology & Oncology Physician	$113.4K	$0
Jeremy Rosiecki	AK	Physician Assistant	$97.2K	$0

Nearby Providers

Other providers in the same ZIP code as Natalie Wallace, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alaska Native Tribal Health Consortium	AK	General Acute Care Hospital	$0	$397.1M
Providence Health & Services Washington	AK	General Acute Care Hospital	$0	$161.5M
Southcentral Foundation	AK	Community Health Clinic/Center	$0	$130.3M
Alaska Native Tribal Health Consortium	AK	Transportation Broker	$0	$65.5M
The Arc Of Anchorage	AK	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$50.8M
Good Samaritan Care Services	AK	In Home Supportive Care Agency	$0	$46.1M
Alaska Native Tribal Health Consortium	AK	General Acute Care Hospital	$0	$33.1M
Galen Hospital Alaska, Inc.	AK	General Acute Care Hospital	$0	$31.8M
Anchorage Community Mental Health	AK	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$31.7M
Patient Housing At Anmc	AK	General Acute Care Hospital	$0	$31M

Natalie Wallace — Billing Profile & Reimbursement Data

Sign up for Natalie Wallace — Billing Profile & Reimbursement Data policy alerts

Natalie Wallace — Billing Profile & Reimbursement Data

Sign up for Natalie Wallace — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References